Status:
RECRUITING
Investigation of Respiratory Muscle Sarcopenia in Patients with Systemic Sclerosis
Lead Sponsor:
Selcuk University
Conditions:
Systemic Sclerosis (SSc)
Scleroderma
Eligibility:
All Genders
18-75 years
Brief Summary
The aim of this study was to investigate respiratory muscle sarcopenia in individuals with systemic sclerosis. The main question it aims to answer is: What is the prevalence of respiratory muscle sar...
Detailed Description
Sarcopenia is a generalized and progressive loss of skeletal muscles and is characterized by a decrease in muscle strength, muscle mass and physical performance. It usually occurs in older people, but...
Eligibility Criteria
Inclusion
- Being between the ages of 18-75
- 2013 To be diagnosed with systemic sclerosis according to ACR/EULAR classification criteria
- Being clinically stable
- Ability to adapt to tests (visual, cognitive, cooperative)
Exclusion
- Those with neurological and/or musculoskeletal problems that may affect the work
- Presence of severe joint contracture or painful ulcers that may affect muscle strength measurement and walking
- Presence of severe infection or sepsis
- Being diagnosed with a known additional rheumatologic disease
- Any stage of cancer
- Pregnant or breastfeeding
Key Trial Info
Start Date :
July 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT06598982
Start Date
July 1 2024
End Date
July 1 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Selcuk University
Konya, Selcuklu, Turkey (Türkiye), 42250